141 related articles for article (PubMed ID: 7841317)
1. Evaluation of a modified procedure for Staclot LA for the confirmation of lupus anticoagulants.
Charles LA; McGlasson DL; Hawksworth BA; Ashcraft JH; Ortel TL
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):601-4. PubMed ID: 7841317
[TBL] [Abstract][Full Text] [Related]
2. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
Tripodi A; Chantarangkul V; Clerici M; Mannucci PM
Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of sensitivity and specificity of a standardized procedure using different reagents for the detection of lupus anticoagulants. The Working Group on Hemostasis of the Société Française de Biologie Clinique and for the Groupe d'Etudes sur I'Hémostase et la Thrombose.
Goudemand J; Caron C; De Prost D; Derlon A; Borg JY; Sampol J; Sié P
Thromb Haemost; 1997 Feb; 77(2):336-42. PubMed ID: 9157593
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of sensitivity and specificity of confirmatory assays for lupus anticoagulant (LA) detection].
Imoto K; Yasumuro Y; Taki M; Suzuki Y; Akatu S; Tajima C; Ichikawa Y
Rinsho Byori; 1996 Aug; 44(8):797-801. PubMed ID: 8816068
[TBL] [Abstract][Full Text] [Related]
5. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification.
Triplett DA; Barna LK; Unger GA
Thromb Haemost; 1993 Nov; 70(5):787-93. PubMed ID: 8128436
[TBL] [Abstract][Full Text] [Related]
6. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
7. Laboratory diagnosis of lupus anticoagulants--effect of residual platelets in plasma, assessed by Staclot LA and silica clotting time.
Chantarangkul V; Tripodi A; Clerici M; Bressi C; Mannucci PM
Thromb Haemost; 2002 May; 87(5):854-8. PubMed ID: 12038789
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the reagent "IL Test LAC Screen/IL Test LAC Confirm" for the biological diagnosis of circulating lupus anticoagulants].
Magdelaine A; Verdy E
Ann Biol Clin (Paris); 1996; 54(7):293-6. PubMed ID: 8952726
[TBL] [Abstract][Full Text] [Related]
9. Detection of procoagulant phospholipid interfering in tests for lupus anticoagulant.
Exner T; Low J
Thromb Res; 2004; 114(5-6):547-52. PubMed ID: 15507290
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of recently described tests for detection of the lupus anticoagulant.
Forastiero RR; Cerrato GS; Carreras LO
Thromb Haemost; 1994 Nov; 72(5):728-33. PubMed ID: 7900080
[TBL] [Abstract][Full Text] [Related]
11. The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers.
Lawrie AS; Mackie IJ; Purdy G; Machin SJ
Thromb Haemost; 1999 May; 81(5):758-62. PubMed ID: 10365750
[TBL] [Abstract][Full Text] [Related]
12. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
[TBL] [Abstract][Full Text] [Related]
13. The sensitivity of different coagulation reagents to the presence of lupus anticoagulants.
Brandt JT; Triplett DA; Musgrave K; Orr C
Arch Pathol Lab Med; 1987 Feb; 111(2):120-4. PubMed ID: 3101649
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a new silica clotting time in the diagnosis of lupus anticoagulants.
Devreese KM
Thromb Res; 2007; 120(3):427-38. PubMed ID: 17156825
[TBL] [Abstract][Full Text] [Related]
15. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
16. Are laboratories following published recommendations for lupus anticoagulant testing? An international evaluation of practices.
Moffat KA; Ledford-Kraemer MR; Plumhoff EA; McKay H; Nichols WL; Meijer P; Hayward CP
Thromb Haemost; 2009 Jan; 101(1):178-84. PubMed ID: 19132206
[TBL] [Abstract][Full Text] [Related]
17. The effect of lupus anticoagulant in the second-generation assay for activated protein C resistance.
Ragland BD; Reed CE; Eiland BM; Tichenor PH; Hudson CL; Fritsma GA; Adler BK; Marques MB
Am J Clin Pathol; 2003 Jan; 119(1):66-71. PubMed ID: 12520699
[TBL] [Abstract][Full Text] [Related]
18. Conceptions and misconceptions in testing for lupus anticoagulants.
Exner T
J Autoimmun; 2000 Sep; 15(2):179-83. PubMed ID: 10968906
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of lupus anticoagulant in the lupus anticoagulant-hypoprothrombinemia syndrome: report of two cases and review of the literature.
Baca V; Montiel G; Meillón L; Pizzuto J; Catalán T; Juan-Shum L; Nieva B
Am J Hematol; 2002 Nov; 71(3):200-7. PubMed ID: 12410576
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic methodologies for circulating anticoagulants.
Exner T
Thromb Haemost; 1995 Jul; 74(1):338-44. PubMed ID: 8578481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
